The company said net revenues for Q3 grew 5% to $12.5 billion, organic revenues (non-GAAP) grew 6%, operating income grew 59%, and EPS grew 30% to $0.86.

1. 01

   The company said net revenues for Q3 grew 5% to $12.5 billion, organic revenues (non-GAAP) grew 6%, operating income grew 59%, and EPS grew 30% to $0.86.

2. 02

   The company said operating margin for Q3 was 32.0% (versus 21.2% in the prior-year period), and comparable operating margin (non-GAAP) was 31.9% (versus 30.7% in the prior-year period). Comparable EPS (non-GAAP) grew 6% to $0.82.

3. 03

   The company said year-to-date cash flow from operations through the end of Q3 was $3.7 billion and free cash flow (non-GAAP) was $2.4 billion, which reflects the fairlife contingent consideration payment of $6.1 billion made in Q1. Year-to-date free cash flow excluding this payment (non-GAAP) was $8.5 billion.

4. 04

   The company gave an outlook for organic revenue (non-GAAP) growth of 5% to 6% for the full year, which is unchanged, and for free cash flow excluding the fairlife payment (non-GAAP) of at least $9.8 billion, changed from $9.5 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.